Determinants of antiretroviral therapy coverage in Sub-Saharan Africa
Among 35 million people living with the human immunodeficiency virus (HIV) in 2013, only 37% had access to antiretroviral therapy (ART). Despite global concerted efforts to provide the universal access to the ART treatment, the ART coverage varies among countries and regions. At present, there is a...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English English |
| Published: |
PeerJ
2015
|
| Subjects: | |
| Online Access: | https://eprints.ums.edu.my/id/eprint/29295/1/Determinants%20of%20antiretroviral%20therapy%20coverage%20in%20Sub-Saharan%20Africa.pdf https://eprints.ums.edu.my/id/eprint/29295/2/Determinants%20of%20antiretroviral%20therapy%20coverage%20in%20Sub-Saharan%20Africa1.pdf https://eprints.ums.edu.my/id/eprint/29295/ https://peerj.com/articles/1496/ http://dx.doi.org/10.7717/peerj.1496 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Among 35 million people living with the human immunodeficiency virus (HIV) in 2013, only 37% had access to antiretroviral therapy (ART). Despite global concerted efforts to provide the universal access to the ART treatment, the ART coverage varies among countries and regions. At present, there is a lack of systematic empirical analyses on factors that determine the ART coverage. Therefore, the current study aimed to identify the determinants of the ART coverage in 41 countries in SubSaharan Africa. It employed statistical analyses for this purpose. Four elements, namely, the HIV prevalence, the level of national income, the level of medical expenditure and the number of nurses, were hypothesised to determine the ART coverage. The findings revealed that among the four proposed determinants only the HIV prevalence had a statistically significant impact on the ART coverage. In other words, the HIV prevalence was the sole determinant of the ART coverage in Sub-Saharan Africa. |
|---|